Overview
Leslye Ingersoll is a Radiation Oncologist in Ogden, Utah. Dr. Ingersoll is highly rated in 1 condition, according to our data. Her top areas of expertise are Breast Cancer, Intraductal Papilloma, Thymic Epithelial Tumor, and Angiosarcoma.
Her clinical research consists of co-authoring 1 peer reviewed article and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
4401 Harrison Blvd, Ogden, UT 84403
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Radiation Oncology - Sugarhouse
David Gaffney is a Radiation Oncologist in Salt Lake City, Utah. Dr. Gaffney is highly rated in 10 conditions, according to our data. His top areas of expertise are Cervical Cancer, Endometrial Cancer, Vulvar Cancer, and Breast Cancer. Dr. Gaffney is currently accepting new patients.
Hcd Radiation Oncology
Charles Rogers is a Radiation Oncologist in Layton, Utah. Dr. Rogers is highly rated in 18 conditions, according to our data. His top areas of expertise are Radiation Induced Meningioma, Meningioma, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Rogers is currently accepting new patients.
Radiation Oncology - Sugarhouse
Jonathan Tward is a Radiation Oncologist in Salt Lake City, Utah. Dr. Tward is highly rated in 6 conditions, according to our data. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Prostatectomy, and Reconstructive Urology Surgery. Dr. Tward is currently accepting new patients.
Frequently Asked Questions about Dr. Leslye Ingersoll
How do I make an appointment with Dr. Leslye Ingersoll?
You can book an appointment with Dr. Leslye Ingersoll by calling their office at 801-387-7400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Leslye Ingersoll a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Leslye Ingersoll is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Leslye Ingersoll specialize in?
While Dr. Leslye Ingersoll is a Radiation Oncology, they have specific expertise in Breast Cancer, Intraductal Papilloma, and Thymic Epithelial Tumor. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.
Does Dr. Leslye Ingersoll participate in research or clinical trials?
Yes. Dr. Leslye Ingersoll has published 1 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Leslye Ingersoll's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Ingersoll isAdvanced. Learn about Breast Cancer.
- Experienced
- AngiosarcomaDr. Ingersoll isExperienced. Learn about Angiosarcoma.
- Intraductal PapillomaDr. Ingersoll isExperienced. Learn about Intraductal Papilloma.
- Thymic Epithelial TumorDr. Ingersoll isExperienced. Learn about Thymic Epithelial Tumor.